Cargando…

Novel intracellular function of IL-1 receptor antagonist type 1 in endothelial cells

Detalles Bibliográficos
Autores principales:	Gabay, C, Soussi, F, Berti, M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833863/ http://dx.doi.org/10.1186/ar873

Ejemplares similares

Intracellular IL-1 receptor antagonist (icIL-1Ra1) does not antagonize growth inhibitory effects of pre-IL-1α in SaOS-2 cells
por: Palmer, G, et al.
Publicado: (2005)

IL-1 beta receptor antagonist efficacy in the treatment of idiopathic recurrent pericarditis
por: Picco, P, et al.
Publicado: (2008)

Recurrent poliserositis succesfully treated with IL-1 receptor antagonist Anakinra
por: Lovillo, MS Camacho, et al.
Publicado: (2011)

IL-1 receptor antagonist restores IL-18 NK cell axis in systemic JIA
por: Vastert, Sebastiaan J, et al.
Publicado: (2012)

Deficiency of Interleukin-1 Receptor Antagonist (DIRA): Report of the First Indian Patient and a Novel Deletion Affecting IL1RN
por: Mendonca, LO, et al.
Publicado: (2015)

Different molecules at the surface of stimulated T cells induce IL-1α, tumor necrosis factor and IL-1 receptor antagonist in human monocytes
por: Burger, D, et al.
Publicado: (2004)

Intracellular IL-1Ra exhibits unique antiinflammatory properties
por: Arend, WP, et al.
Publicado: (2004)

Effect of IL-1 receptor antagonist on the cerebrospinal fluid nitric oxide concentrations during experimental polymicrobial sepsis in rats
por: Wahab, Fazal, et al.
Publicado: (2013)

IL-33: a novel cytokine with proinflammatory properties
por: Palmer, Gaby, et al.
Publicado: (2007)

Production of interleukin (IL)-1 receptor antagonist by human articular chondrocytes
por: Palmer, G, et al.
Publicado: (2002)

Antagonistic effects of HTLV-1 Tax oncoprotein on BRCA1 expression and function
por: Huleihel, Mahmoud, et al.
Publicado: (2014)

The IL-1 receptor antagonist anakinra (kineret®) stabilizes the NLRP3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (CAPS)
por: Leinonen, Mika, et al.
Publicado: (2014)

Effects of leflunomide on interleukin-1 receptor antagonist (IL-1Ra) synthesis in chondrocytes and synovial fibroblasts
por: Palmer, G, et al.
Publicado: (2003)

Interleukin-1 receptor antagonist treatment revealed active hepatitis B infection in a boy with PAPA syndrome
por: Selmanovic, V, et al.
Publicado: (2015)

Interleukin-1 antagonists in Mevalonate Kinase Deficiency
por: Galeotti, C, et al.
Publicado: (2011)

Identification of a functional SNP in an asthma gene: IL1RL1
por: Akhabir, Loubna, et al.
Publicado: (2010)

Physiologic role of interleukin-1 receptor antagonist
por: Arend, William P, et al.
Publicado: (2000)

Turkish DIRA patient with novel IL1RN gene mutation
por: Berdeli, A, et al.
Publicado: (2015)

Interleukin-1 receptor antagonist lentiviral gene transfer to the murine knee joint ameliorates collagen-induced arthritis
por: van de Loo, FAJ, et al.
Publicado: (2005)

Intracellular Function of Interleukin-1 Receptor Antagonist in Ischemic Cardiomyocytes
por: Vecile, Elena, et al.
Publicado: (2013)

Novel role of platelet endothelial cell adhesion molecule-1 (PECAM-1) in facilitating TGF-beta-mediated inhibition of T cell function
por: Newman, Debra, et al.
Publicado: (2015)

Different pattern of synthesis and secretion of IL-1beta in patients with CIAS-1 and TNFRSF1A mutations responding to IL-1 blockade
por: Lasigliè, D, et al.
Publicado: (2008)

Secreted IL-1Ra exerts a protective effect on atherosclerotic lesion development in apolipoprotein-E-deficient mice
por: Soussi, F, et al.
Publicado: (2003)

A phenotypic shift after initiation of IL-1 receptor blockade in a boy with systemic juvenile arthritis
por: Scott, C, et al.
Publicado: (2008)

Calcium ionophore pre-treatment induces type-1 polarized DCs with enhanced T cell stimulatory function and IL-12 production
por: Berk, Erik, et al.
Publicado: (2013)

Synergistic and antagonistic AML cell type-specific responses to 5-AZA-2’-Deoxycytidine and 1-H-D-Arabinofuranosylcytosine
por: Elmoneim, Abeer Abd, et al.
Publicado: (2014)

Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors
por: Perez Horta, Zulmarie, et al.
Publicado: (2014)

Our experience with the use of the Interleukin-1 receptor antagonist in the treatment of the patient with CINCA/NOMID syndrome (case study - 5 years of therapy)
por: Vargova, V, et al.
Publicado: (2011)

Hearing improvement in a variant Muckle–Wells syndrome case in response to IL-1 receptor antagonism
por: Rynne, M, et al.
Publicado: (2005)

Gastrin-releasing peptide receptor antagonist induces a protection from lethal sepsis: involvement of toll-like receptor 4 signaling
por: Petronilho, F, et al.
Publicado: (2010)

Peroxisome proliferator-activated receptor gamma 1 expression is diminished in human osteoarthritis cartilage and is downregulated by IL-1β in articular chondrocytes
por: Afif, H, et al.
Publicado: (2007)

The effect of the CGRP receptor antagonist (MK-8825) on the response to trigeminal nociception in rodents
por: Romero-Reyes, M, et al.
Publicado: (2013)

TLR7/9 antagonist reduces HIV-1-induced immune activation
por: Chang, J, et al.
Publicado: (2012)

Novel positive allosteric modulators of sigma-1 receptor
por: Vavers, Edijs, et al.
Publicado: (2015)

IL-1 but not IL-18 induces osteoprotegerin and TRAIL in rheumatoid arthritis synovial fibroblasts
por: Morel, J, et al.
Publicado: (2003)

IL-1-driven cartilage and bone destruction are dependent on Toll-like receptor (TLR) 4, but not TLR2
por: Abdollahi-Roodsaz, S, et al.
Publicado: (2005)

Novel mutation of the LPIN2 gene in Turkish brothers with Majeed syndrome. Response to IL-1 inhibition
por: Herlin, T, et al.
Publicado: (2011)

Activation of peroxisome proliferator-activated receptor γ inhibits IL-1β-induced mPGES-1 expression in human synovial fibroblasts by interfering with Egr-1
por: Cheng, S, et al.
Publicado: (2004)

NLRP3 Q703K and TNFRSF1A R92Q mutations in a patient with auto inflammatory disease
por: von Mühlenen, I, et al.
Publicado: (2015)

PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis
por: Finetti, M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nonbdai6g1hk15k6vjhhu5bb8p